• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number 3MAXC
Device Problems Fracture (1260); Stretched (1601); Physical Resistance/Sticking (4012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/10/2023
Event Type  malfunction  
Event Description
The patient was undergoing a thrombectomy procedure in the m1 segment of the middle cerebral artery (mca) using a penumbra system red 72 reperfusion catheter (red72), a penumbra system 3max reperfusion catheter (3maxc), a benchmark bmx96 access system (benchmark max), and a guidewire.During the procedure, the 3maxc was advanced over the guidewire to the target location.Subsequently, the physician made several attempts to advance the red72 over the 3maxc to the target location, without success.While removing the red72 and 3maxc together, the physician experienced resistance and applied force to remove the devices.Upon removal, the physician observed that the proximal end of the red72 was stretched and the 3maxc was fractured at the distal end.Therefore, the red72 and the 3maxc were no longer used in the procedure.The procedure was completed using a penumbra system red 68 reperfusion catheter (red68), the same benchmark max, a non-penumbra microcatheter, and a stent retriever to perform a combined technique of aspiration and clot retrieval using the stent retriever.There was no report of an adverse effect to the patient.
 
Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.H3 other text : placeholder.
 
Manufacturer Narrative
Evaluation of the returned 3maxc confirmed that the catheter was fractured and revealed yield marks near the fractured location.If the 3maxc is retracted against resistance, damage such as a fracture may occur.Further evaluation revealed additional yield marks on the catheter shaft.This damage was incidental to the reported complaint and likely occurred during retraction of the device against resistance at an angle during removal of the device.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key16811527
MDR Text Key314128788
Report Number3005168196-2023-00197
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00814548019956
UDI-Public814548019956
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K160449
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/01/2005,04/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number3MAXC
Device Lot NumberF00003435
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 03/31/2023
Initial Date FDA Received04/25/2023
Supplement Dates Manufacturer Received03/15/2024
Supplement Dates FDA Received04/11/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/05/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age59 YR
-
-